Tag: ASPECTS
Stroke thrombectomy: Limitless potential or a success story nearing its final...
Mechanical thrombectomy has gone from strength to strength in the treatment of acute ischaemic stroke over the past decade—progressing beyond early-window large vessel occlusions...
Avicenna.AI secures US FDA 510(k) clearance for two AI-powered imaging tools
Avicenna.AI announced today that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for its CINA-ASPECTS and CINA-iPE products.
CINA-ASPECTS is...
Rapid ASPECTS receives CADx clearance from the FDA
RapidAI has announced that Rapid ASPECTS has received US Food and Drug Administration (FDA) clearance as the first neuroimaging analysis device in the CADx (computer-assisted...
Thrombectomy fails to find a benefit in the older population with...
A low Alberta stroke program early CT score (ASPECTS) of 4–5 has been deemed the threshold for mechanical thrombectomy, with no benefit elicited in...
SNIS 2019: It is “almost unethical” not to broaden thrombectomy inclusion...
Donald Frei (Denver, USA) talks to BLearning at SNIS 2019 (22–25 July, Miami, USA) to discuss recent data from the cohort of thrombectomy trials which has shown...
